Laboratory tests have a key role in preventing human papillomavirus (HPV)–driven
carcinomas and in guiding therapeutic interventions. An understanding of the virology …

Human Papillomavirus (HPV) is the most common sexually transmitted virus. Worldwide, the
most common high-risk (HR)-HPV are-16/18, and approximately 70% of cervical cancers …

The advent of US Food and Drug Administration (FDA)-approved molecular testing for
human papillomavirus (HPV) has resulted in a dramatic shift from cytological testing alone to …

Nucleic acid‐based high‐risk human papillomavirus (hrHPV) testing is essential to
contemporary cervical cancer screening. The numbers of commercially available assays …

Abstract Human Papilloma Virus (HPV) is becoming a menace worldwide, especially to the
developing world, due to its involvement in a variety of malignancies, with cervical cancer …

Background Molecular tests for detection of human papillomaviruses (HPVs) play a crucial
role in the prevention of cervical cancer, including recently announced elimination efforts …

Commercial molecular tests for human papillomaviruses (HPV) are invaluable diagnostic
tools in cervical carcinoma screening and management of women with cervical …

Human papillomaviruses (HPVs) comprise more than 180 genotypes. HPV infection is
mainly diagnosed by molecular methods. The aim of our study was to review the main …

Purpose: Human papillomavirus (HPV) infection is the most common sexually transmitted
infection in the United States. This review summarizes the molecular testing methods …

The biological importance of human papillomavirus (HPV) in the field of medicine–related to
cervical carcinogenesis–has been extensively reported in the last decades. For the first time …